RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Selling, general & administrative

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$109.6B
P/E ratio
SummaryFinancials
Period EndSelling, general & administrative (Million USD)YoY (%)
Dec 31, 20241,464+28.83%
Dec 31, 20231,137+20.31%
Dec 31, 2022945+12.45%
Dec 31, 2021840+9.04%
Dec 31, 2020770+17.00%
Dec 31, 2019658+18.09%
Dec 31, 2018558+12.40%
Dec 31, 2017496+14.61%
Dec 31, 2016433+14.94%
Dec 31, 2015377+23.30%
Dec 31, 2014305-15.71%
Dec 31, 2013362-17.05%
Dec 31, 2012437+9.00%
Dec 31, 2011401+113.38%
Dec 31, 2010188

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)